AxoGen, Inc.
AxoGen, Inc. (AXGN) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · AXGN · as of Jun 8, 2026
Key Statistics
Explore AxoGen, Inc. Data
axgn stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 19 · Buy rate: 84.2%
The AXGN analyst consensus is Buy, based on ratings from 19 Wall Street analysts over the past 3 months. The average 12-month price target is $47.00, representing +9.81% upside from the current price of $42.80.
Competitors & Peers
axgn competitorsAXGN
AHCO
CTEV
IART
INMD
IRMDStock Performance
Full HistoryAbout AxoGen, Inc.
AxoGen, Inc. together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biol…
what is axogen, inc. · axgn stock overview · axogen, inc. company profile · who is axogen, inc. ceo · axgn NASDAQ · axogen, inc. headquarters · axogen, inc. business segments
About Stock Overview & Key Data
AxoGen, Inc. (AXGN) is a Healthcare company in the Medical - Devices industry, listed on NASDAQ since Dec 17, 1986. As of the latest trading session, AXGN stock price is $42.80, with a market capitalization of $2.3B. The stock has returned +311.14% over the past 12 months and +30.77% year-to-date.
According to 19 Wall Street analysts, the consensus rating for AxoGen, Inc. stock is Buy, with an average 12-month price target of $47.00. In fiscal year 2025, AxoGen, Inc. reported revenue of $225.2M and net income of -$15.7M. For detailed data — including AxoGen, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, AxoGen, Inc. (AXGN) stock price is $42.80. The stock is traded on NASDAQ under the ticker symbol AXGN. The 52-week range is $9.22 – $45.83.